Evolocumab for the treatment of familial hypercholesterolemia

Abstract

Familial hypercholesterolaemia is a common inherited monogenic metabolic disorder. The disease is associated with the significant elevation of atherogenic low-density lipoprotein cholesterol in plasma.

Keywords

• familial hypercholesterolemia
• hypolipidemic treatment
• cardiovascular risk
• atherosclerosis
• evolocumab